期刊文献+

工程菌LacU V5par8egf产hEGF发酵方法的比较 被引量:1

The studies on hEGF productions by recombinant E.Coli harboring expression LacU V5par8egf in batch fermentation
下载PDF
导出
摘要 目的 :明确培养条件对工程菌 L ac U V5 par8egf表达水平和质粒稳定性的影响。方法 :采用优化 MBL培养基 ,利用摇瓶发酵研究工程菌 L ac U V5 par8egf的最优培养条件 ,并与 2 L发酵罐上的发酵进行比较。结果 :摇瓶发酵的最优培养条件为 :温度 32℃ ,接种量 10 % ,种子液 OD5 5 0 1.0~ 3.0 ,装液量 10 % ,摇床转速 2 2 0 rpm;摇瓶发酵的最优诱导条件是在对数生长中后期诱导 ,IPTG最适浓度为 0 .2 m M。 2 L 发酵罐发酵与摇瓶发酵相比 ,发酵周期缩短了约三分之一 ,h EGF表达水平接近摇瓶中发酵水平 ,达到 2 7.7m g/L。结论 :利用摇瓶最优培养条件 ,较好实现了重组 h OBJECTIVE:Clarifying the fermentation conditions of hEGF production by recombinant E.coli harboring expression LacUV5par8egf and plasmid stability was our objective.METHODS:The detalied optimized fermentation conditions in the shaken culture in MBL medium had been studied.The fermentation in shaken flask and 2L bench top fermentor had been compared too.RESULTS:In the shaken culture,the detailed optimized fermentation conditions were obtained as following:temperature 32℃,inoculum volume 10%(V/V),inoculum age OD 550 1.0~3.0,medium volume10%(V/V),rotating speed 220 rpm.It was also shown that induction conditions could affect hEGF accumulation obviously.The maximum hEGF production was attained when the induction was done at middle or late logarithmic phase.The addition of 0.2 mM IPTG led to the highest hEGF accumulation.The fermentation time in 2L bench top fermentors was two thirds of the time in shaken culture,But hEGF in concentration of 27.7 mg/L was almost equal to which in shaken culture.CONCLUSION:The enlarged fermentation from shaken flask to fermentor was successful.
作者 柯世省
出处 《中国现代应用药学》 CAS CSCD 北大核心 2001年第3期209-212,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 间歇发酵 工程菌 LacUV5par8egf HEGF batch fermentation,recombinant E. coli,LacU V5par9egf,hEGF
  • 相关文献

参考文献6

  • 1[1]Heldin H., Westermark B.. Growth factors: Mechmlsm of actkm, and relation to oncogenes,Cell, 1984,37:9,
  • 2[2]Harper R.A., Pierce J, Savage C.R. Methods Enzymol, I987, I46:3.
  • 3[3]Wong W.K.R, Sutherlmtd M.L. Excretion of heterologous proteffts from E. coti, U.S.P. 1993,5:223.
  • 4[4]Hamsa P.V., Kackroo P., Chattoo B.B.Production and Secretion of Biologically-Active Human Epidermal Growth. Factors inrarrowta-Ltpotytica, Current Genetics, 1998,33:231.
  • 5[5]Zhang z. Chizti YM,Moo-Young, Plasmid itt recombinant Saccharomyces cerevisiae.Biotechnol.Advance. 1996, 14:401.
  • 6[6]Imanaka T., Aiba S., A perspective on the appeming of genetic engineering: Stablity of recombinant plasmid, Ann.N.Y.Acad. Sci. 1981,369:1

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部